arginyl-glycyl-aspartyl-serine has been researched along with Injuries, Spinal Cord in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gimble, JM; Gomes, ED; Leite-Almeida, H; Mendes, SS; Salgado, AJ; Shoichet, MS; Silva, NA; Sousa, N; Tam, RY | 1 |
1 other study(ies) available for arginyl-glycyl-aspartyl-serine and Injuries, Spinal Cord
| Article | Year |
|---|---|
Combination of a peptide-modified gellan gum hydrogel with cell therapy in a lumbar spinal cord injury animal model.
Topics: Animals; Combined Modality Therapy; Hydrogels; Lumbar Vertebrae; Nerve Regeneration; Oligopeptides; Polysaccharides, Bacterial; Rats; Rats, Wistar; Spinal Cord Injuries; Stem Cell Transplantation; Treatment Outcome | 2016 |